IL325619A - טיפול משולב - Google Patents

טיפול משולב

Info

Publication number
IL325619A
IL325619A IL325619A IL32561925A IL325619A IL 325619 A IL325619 A IL 325619A IL 325619 A IL325619 A IL 325619A IL 32561925 A IL32561925 A IL 32561925A IL 325619 A IL325619 A IL 325619A
Authority
IL
Israel
Prior art keywords
combination therapy
therapy
combination
Prior art date
Application number
IL325619A
Other languages
English (en)
Inventor
Bill Vestergaard
Original Assignee
Zealand Pharma As
Bill Vestergaard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zealand Pharma As, Bill Vestergaard filed Critical Zealand Pharma As
Publication of IL325619A publication Critical patent/IL325619A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
IL325619A 2023-06-30 2025-12-25 טיפול משולב IL325619A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP23182749 2023-06-30
EP23203438 2023-10-13
PCT/EP2024/068365 WO2025003471A1 (en) 2023-06-30 2024-06-28 Combination therapy

Publications (1)

Publication Number Publication Date
IL325619A true IL325619A (he) 2026-02-01

Family

ID=91781898

Family Applications (1)

Application Number Title Priority Date Filing Date
IL325619A IL325619A (he) 2023-06-30 2025-12-25 טיפול משולב

Country Status (8)

Country Link
EP (1) EP4735021A1 (he)
KR (1) KR20260032481A (he)
CN (1) CN121443305A (he)
AU (1) AU2024306538A1 (he)
IL (1) IL325619A (he)
MX (1) MX2025015168A (he)
TW (1) TW202517291A (he)
WO (1) WO2025003471A1 (he)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100745C (en) 1991-11-19 2007-07-31 Laura S. L. Gaeta Amylin agonist peptides and uses therefor
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
US6451987B1 (en) 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
CZ20013018A3 (cs) 1999-03-17 2002-02-13 Novo Nordisk A/S Způsob pro acylování aminoskupiny peptidu nebo proteinu a sloučenina
DE102004051014A1 (de) 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
AR080592A1 (es) 2010-03-26 2012-04-18 Lilly Co Eli Peptido con actividad para el gip-r y glp-1-r, formulacion famaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de diabetes mellitus y para inducir la perdida de peso
JP6121992B2 (ja) 2011-06-10 2017-04-26 ノヴォ ノルディスク アー／エス ポリペプチド
IN2014MN02304A (he) 2012-05-03 2015-08-07 Zealand Pharma As
SI3004155T1 (sl) 2013-05-28 2022-02-28 Takeda Pharmaceutical Company Limited Peptidna spojina
TWI582109B (zh) 2015-01-09 2017-05-11 美國禮來大藥廠 Ｇｉｐ及ｇｌｐ－１共促效劑化合物
US10071140B2 (en) 2016-09-09 2018-09-11 Zealand Pharma A/S Amylin analogues
SG11202100112YA (en) * 2018-07-23 2021-02-25 Lilly Co Eli Methods of using a gip/glp1 co-agonist for therapy

Also Published As

Publication number Publication date
TW202517291A (zh) 2025-05-01
CN121443305A (zh) 2026-01-30
AU2024306538A1 (en) 2025-12-04
AU2024306538A9 (en) 2026-01-08
WO2025003471A1 (en) 2025-01-02
MX2025015168A (es) 2026-02-03
EP4735021A1 (en) 2026-05-06
KR20260032481A (ko) 2026-03-09

Similar Documents

Publication Publication Date Title
IL319599A (he) טיפול קומבינציה
CA221425S (en) Therapy eye-mask
IL304223A (he) טיפול משולב
GB202104037D0 (en) Combination therapy
GB202004189D0 (en) Combination therapy
IL318268A (he) טיפול משולב
GB202002639D0 (en) Therapy
GB202111288D0 (en) Combination therapy
IL325619A (he) טיפול משולב
GB202318311D0 (en) Combination therapy
GB202317996D0 (en) Combination therapy
GB202316168D0 (en) Combination therapy
GB202315149D0 (en) Combination therapy
GB202314243D0 (en) Combination therapy
GB202314157D0 (en) Combination therapy
GB202306663D0 (en) Combination therapy
GB202218974D0 (en) Combination therapy
GB202207792D0 (en) Combination therapy
GB202205317D0 (en) Combination therapy
GB202201346D0 (en) Combination therapy
GB202315877D0 (en) Therapy
GB202306835D0 (en) Therapy
GB202306826D0 (en) Therapy
GB202306833D0 (en) Therapy
GB202303026D0 (en) Therapy